Publishers need to be proactive about detecting and deterring copied text.
Critic At Large
Most Recent
Advances in genomics and cancer biology will alter the design of human cancer studies.
Twenty-first century lab reports will include test results read by a new breed of pathologist.
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Grading journals on how well they share information with readers will help deliver accountability to an industry that often lacks it.
Overzealous open-access advocates are creating an exploitative environment, threatening the credibility of scholarly publishing.
False credit for scientific discoveries threatens the success and pace of research.
Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.
Subjects
- culture
- disease/medicine
- funding
- opinion
- policy
- public health
- publishing
- science policy
- science publishing
- techniques
Sub Categories
- Bio Business
- Capsule Reviews
- Careers
- Contributors
- Critic At Large
- Editorial
- Features
- Foundations
- Lab Tools
- Modus Operandi
- Notebook
- Profile
- Reading Frames
- Scientist to Watch
- Speaking of Science
- Special Section
- The Literature
- Thought Experiment
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
